Skip to main content
Download PDF
Download ePub

Projected impact of diabetes on the Costa Rican healthcare system

International Journal for Equity in Health volume 19, Article number: 172 (2020) Cite this article

Abstract

Introduction

Costa Rica, similar to many other Latin American countries is undergoing population aging at a fast pace. As a result of the epidemiological transition, the prevalence of diabetes has increased. This condition impacts not only individual lives, but also the healthcare system. The goal of this study is to examine the expected impact of diabetes, in terms of economic costs on the healthcare system and lives lost. We will also project how long it will take for the number of elderly individuals who are diabetic to double in Costa Rica.

Methods

CRELES (Costa Rican Longevity and Healthy Aging Study), a three-wave nationally representative longitudinal study, is the main source of data for this research (n = 2827). The projected impact of diabetes was estimated in three ways: length of time for the number of elderly individuals with diabetes to double; projected economic costs of diabetes-related hospitalizations and outpatient care; and years of life lost to diabetes at age 60. Data analyses and estimations used multiple regression models, longitudinal regression models, and Lee-Carter stochastic population projections.

Results

Doubling time of the diabetic elderly population is projected to occur in 13 calendar years. This will cause increases in hospitalization and outpatient consultation costs. The impact of diabetes on life expectancy at age 60 around the year 2035 is estimated to lead to a loss of about 7 months of life. The rapid pace at which the absolute number of elderly people with diabetes will double is projected to result in a negative economic impact on the healthcare system. Lives will also be lost due to diabetes.

Conclusion

Population aging will inevitably lead to an increasing number of elderly individuals, who are at greater risk for diabetes due to their lifelong exposure to risk factors. Actions to increase the quality of life of diabetic elderly are warranted. Decreasing the burden of diabetes on elderly populations and the Costa Rican healthcare system are necessary to impact the quantity and quality of life of incoming cohorts. Health promotion and prevention strategies that reduce diabetes risk factors are needed to improve the health of elderly populations.

Introduction

Diabetes mellitus is a chronic disorder of carbohydrate, fat, and protein metabolism characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. There are two main forms of diabetes. Type 1 diabetes is due to an absolute insulin deficiency that requires patients to take exogenous insulin for survival. Its frequency is low relative to type 2 diabetes, which accounts for over 90% of cases globally. Type 2 diabetes (DM2) is characterized by insulin resistance and abnormal insulin secretion leading to relative rather than absolute insulin deficiency. Overweight and obesity may lead to insulin resistance, which, given genetic susceptibility may in turn lead to type 2 diabetes [35]. Once diagnosed, diabetes patients will have this condition for a lifetime, therefore lifestyle changes including diet and physical activity are usually prescribed. About two-thirds of elderly individuals with type 2 diabetes are treated with oral antihyperglycemic medications [49]. Patients with type 2 diabetes are not dependent on exogenous insulin, although some of them may require it to control their condition [59]. Diabetes mellitus type 2, which is the condition of interest for this study, is considered a public health issue. It is one of the most prevalent conditions and one of the leading causes of death worldwide. In 1980 there was an average of 108 million diabetic people in the world. By 2014 the number was 422 million [57]. Similar to other chronic diseases, diabetes prevalence is higher in low- and middle-income countries. Metabolic conditions, hypertension and diabetes included, have common risk factors, such as obesity. Although subjacent genetic factors play a role, environmental risk factors have been recognized as the most important determinants. Latin America, as a region, has adopted health and nutrition profiles of developed countries, which has contributed to the rise of obesity [1].

Costa Rica is a small Central American country that has achieved outstanding health standards. The current population is approximately 5.1 million, and 13% of Costa Ricans are aged 60 or older [12]. Total life expectancy in Costa Rica is 80 years, higher than life expectancy in the US, which is 78 years. This is despite Costa Rica having a per capita gross national income (GNI) of less than one-fourth that of the USA [34].

Costa Rican medicine is highly socialized. The country has a subsidized healthcare system established in 1941 as part of a government initiative. Since that time, the cost of public healthcare services has been largely paid by the government [41]. In the present day, more than half a century later, Costa Rica’s health policies have improved access to care through public services and universal social health insurance [53]. Government-funded health care is a key determinant of the country’s impressive health indicators. The high life expectancy in Costa Rica has been attributed to the funneling of resources towards education, to a strong primary care focus in the healthcare system, and to the role that a national health insurance fund has had in reducing economic barriers to healthcare access [10]. According to [42], the high life expectancy of Costa Rican adults is driven by the low incidence of conditions such as cardiovascular diseases, lung cancer and breast cancer. Nonetheless, Costa Ricans have a high incidence of diabetes mellitus, stomach cancer and, cervical cancer.

As a result of the demographic and epidemiological transitions in Costa Rica, the causes of morbidity and mortality have shifted from communicable to non-communicable diseases [40]. There has been an increase in diabetes incidence as early as the age of 30, and an important upsurge in the prevalence of diabetes in older adults [17]. Among the Costa Rican elderly, the prevalence is higher at younger ages and decreases with age [45]. This holds true not only for Costa Rica but also for Latin America at large.

Costa Rica, along with other Latin American countries, is in the middle of a diabetes and obesity epidemic which has partially resulted from sedentary habits and a westernized diet. Levels of self-reported diabetes and obesity in Latin America and the Caribbean (LAC) have been found to be as high or even higher than in the USA. In Costa Rica, 6 out of 10 adults are currently overweight or obese. Among the elderly, the prevalence of overweight and obesity is as high as in the younger adult population, with a greater impact on women [32].

Diabetes is currently the fourth cause of death in the elderly and has been increasing for the last three decades in Costa Rica [12]. It is also a well-established risk factor for coronary heart disease (CHD) [21], as well as for cardiovascular and cerebrovascular diseases [3]. Furthermore, hypertension and kidney disease are more prevalent in the diabetic population.

A comparison of diabetes prevalence in Costa Rica, the United States, Mexico, and seven LAC cities is presented in Fig. 1. Although these figures are not strictly comparable in terms of the age of the reference population, or the year the survey was conducted, they all refer to elderly populations and were collected during similar time periods. As Fig. 1 shows, the prevalence in Costa Rica is one of the highest in the region, and is also higher among women in most cities and countries.

Fig. 1
figure 1

Prevalence of diabetes in the elderly population by sex. Selected countries and cities (percentages). Source: Own elaboration based on results from Brenes-Camacho and Rosero-Bixby [8]; McDonald [29]; Andrade [2]

Full size image

LAC countries have generated public policies in an effort to reduce the prevalence of diabetes, including added taxes for sugary drinks. Studies have shown that taxing these products significantly decreases their consumption and promotes the consumption of less unhealthy drinks [37]. Colchero, Popkin and Wen [15] showed that in Mexico, 1 year after the implementation of an excise tax on sugary drinks, purchases fell 6–12%, and purchases of less unhealthy drinks increased in 4%. No tax policies on sugary drinks are currently in place in Costa Rica but, since 2013, regulations applied to school canteens were implemented to reduce the consumption of sugary drinks and processed foods in public schools [31].

The diabetes epidemic has human and economic costs. Some of the costs come from premature mortality and from the burden on the healthcare system which is exacerbated by morbidity associated with diabetes complications. It must be acknowledged, however, that the burden of diabetes on health systems reflects only a fraction of the financial burden incurred by individuals with diabetes, their families and communities. Diabetes imposes costs on society in terms of lower returns on education, decreased income, lost productivity from job absenteeism and mortality, premature retirement and unemployment, and higher dependence on welfare [50, 58].

Diabetes is associated with higher comorbidity and with premature mortality which lead to a loss of both healthy life years and total life years. A study in Colombia conducted during 2006 and 2012 [20] sought to analyze the loss of healthy life years in a Colombian population. They found that among the population with chronic conditions women had a greater loss of healthy life years as compared to men. In other contexts outside Latin America, such as in Finland, it has also been found that diabetes has a negative effect on health-related-quality-of-life (HRQoL). Schanner, Falck, Keskitalo and Hautala [46] found that longer diabetes duration time was associated with a higher quality of life loss.

Little is known about the prevalence of diabetes and the determinants of this condition among elderly populations in Latin America because most epidemiologic studies have focused on the general population or younger population segments [4]. The objective of this study is to project the expected impact of diabetes in terms of doubling time of the diabetic elderly population, economic costs on the healthcare system, and lives lost. The expected impact of diabetes has not been quantified thus far. An estimation of the burden of this condition in the years to come will be an important input for the establishment of public policies that are relevant not only to Costa Rica, but also to other developing countries facing similar scenarios in Latin America.

Methods

CRELES (Costa Rican Longevity and Healthy Aging Study), a three-wave nationally representative longitudinal study, is the main source of data for this research (n = 2827). The baseline interview was conducted between 2004 and 2006, the second wave between 2006 and 2007, and the third wave between 2008 and 2009. Mortality was tracked up to October 31, 2017, by linking the CRELES dataset with the National Death Registry. More details on this survey have been previously published [44, 45].

Self-reports were used to define the diabetes status of individuals. The corresponding items in the questionnaire were: “Has a medical doctor ever told you that you have diabetes or high blood sugar levels?” and “How old were you when you were first told that you had diabetes”. To avoid the potential inclusion of individuals with type 1 diabetes, only individuals reporting a diagnosis at 30 years or older were classified as having the condition. This criterion has been used in other population studies [22, 23, 45, 49].

Sociodemographic variables included in regression models were education, income, sex and age. Education was a dichotomous variable for incomplete/complete primary school; complete primary was defined as six or more years of formal education. Income was a low/high dichotomous variable, with a cut-off point of 50,000 colones (Costa Rican currency) per individual per month. This was equivalent to approximately 100 United States Dollars (USD) during the wave 1 time period (2004–2006). Income was defined as the older person’s own income, if not married, or the couple’s mean monthly income, if married. This income cut-off has been used in similar studies with CRELES [8, 30].

Risk factors included in regression models were body mass index (BMI) and waist circumference, which are indicators of general and abdominal obesity, respectively. As for BMI, individuals were classified as underweight (< 18.5 kg/m2), normal weight (18.5–24.9), overweight (25.0–29.9), or obese (≥30.0 kg/m2) [56]. Waist circumference categories for men were normal (< 94 cm), increased risk of metabolic complications (94–101), and substantially increased risk of metabolic complications (≥102 cm). Waist circumference categories for women were normal (< 80 cm), increased risk of metabolic complications (80–87), and substantially increased risk of metabolic complications (≥88 cm) [56].

Behavioral health risks included in analyses were smoking, alcohol consumption, total daily energy intake, and regular physical activity. Individuals living with a smoking partner were classified as passive smokers, when they were not active smokers themselves. Smoking behavior refers to 100 or more cigarettes or cigars during participants’ lives. Categories were defined as never smoked, former passive or active smoker, current passive smoker, and current active smoker. Alcohol consumption refers to alcoholic beverages ever consumed during individuals’ lives. Categories were defined as never consumed alcohol, former consumer, and current alcohol consumer.

Total daily energy intake was estimated from a 10-min Food Frequency Questionnaire, with a 3000 kcal/day cut-off. This standard cut point is associated with differential risk of cardiovascular disease [9] and has been used in similar population studies [30, 38, 43]. Regular physical activity was defined as three or more days per week of exercise routines or other physical rigorous activities like sports, jogging, dancing, or heavy work during the 12 months preceding the baseline interview.

Geriatric syndromes included in the models were polypharmacy, functional dependency and geriatric depression. Polypharmacy was defined as 5 or more medications daily. Functional dependency was defined as limitations in 7 or more of the 14 activities of daily living (ADL) and the instrumental activities of daily living (IADL). ADL were crossing the bedroom from side to side, bathing, self-feeding, going to bed, toileting, nail trimming, walking, climbing stairs, pushing objects, and raising arms. IADL were cooking, handling money, shopping, and taking medications. The Geriatric Depression Scale (Short Form) which includes 15 items [47] was used to classify participants according to their depression level. Normal was defined as less than 6 depression symptoms; mild depression as 6 to 9 and depression as 10 to 15 depression symptoms.

Health condition variables included in the mortality analyses were previous diagnoses of diabetes, hypertension, dyslipidemia, cardiovascular disease, cancer, and lung disease. Blood pressure was measured twice during the interview, yielding two measures of systolic pressure and two of diastolic pressure. Following Méndez-Chacón et al. [30] individuals were classified as hypertensive if they either had a previous medical diagnosis; or had blood pressure of 140/90 or higher in three out of the four systolic and diastolic measures during the interview; or if they were taking antihypertensive medications.

Dyslipidemia was defined as having at least one of hypercholesterolemia or hypertriglyceridemia. Hypercholesterolemia was defined as Total/HDL ratio of 5.92 or greater. Hypertriglyceridemia was defined as 150 mg/dl or greater. Individuals who were not fasting when their blood sample was taken have missing information on these biomarkers. Cardiovascular disease was defined as the diagnosis of at least one of myocardial infarction, ischemic heart disease without infarction, or stroke.

Data analyses and estimations were conducted with STATA computer software [52]. The analyses include descriptive statistics, multiple regression models, longitudinal regression models, and Lee-Carter stochastic population projections.

Projection of diabetes prevalence in the elderly

To project the expected size of this diabetic elderly population, we first estimated its rates of prevalence, incidence and mortality. The main input for prevalence projections was the incidence and mortality rates computed for 5-year age groups ending in the open 95+ group. In the estimations of the prevalence of diabetes in the elderly, migration was not taken into consideration; only incidence and mortality were allowed to affect prevalence projections. These projections are therefore under the assumptions of null migration and constant incidence and mortality along time.

The size of the diabetic population was computed 5 years back from the year 2006 to the year 2001, and then 5 years back again from the year 2001 to 1996. Growth rates between these time-points were used to project the size of the diabetic population assuming linear growth. Projections were estimated with the following formula:

$$ {{\mathrm{N}}_{\mathrm{x}}}^{\mathrm{d}}=\left[{{\mathrm{N}}_{\mathrm{x}+\mathrm{t}}}^{\mathrm{d}}-\left({\mathrm{N}}_{\mathrm{x}}{\ast}_{\mathrm{t}}{\mathrm{d}}_{\mathrm{x}}\right)\right]/\left(1{-}_{\mathrm{t}}{\mathrm{d}}_{\mathrm{x}}{\ast}_{\mathrm{t}}{\mathrm{q}}_{\mathrm{x}}\right) $$

where:

Nx: Total population at age x

Nxd: Diabetic population at age x

Nxnd: Non-diabetic population at age x

tdx: Diabetes incidence rate for the population aged x to x + t

tqxd: Probability of dying for the diabetic population aged x to x + t

Diabetic population size for each age-group (Nxd) was estimated based on age-specific prevalence rates and the official total population size (Nx) in 2006 [12]. Prevalence rates for the elderly (60+) are this study’s computations from multiple regression models. For the younger adult population (30–59) prevalence rates are the five-year age-group national estimates reported by another study in Costa Rica [39].

Incidence rates in the above formulas (tdx) are this study’s computations from longitudinal regression models for ages 30+ using the respective information on the age of diagnosis (and assuming the absence of selection survival). Death rates for the diabetic population (tmxd) for ages 30–59 are assumed to be the same as all-cause mortality in the general population from the National Death Registry [12]. Death rates for the diabetic population for ages 60+ are this study’s estimates from longitudinal regression models of all-cause mortality in the diabetic elderly. The age-specific probabilities of dying for the diabetic population (tqx) were derived from the tmxd using the relations and separation factors in Coale and Demeny [14] West model life tables.

Based on our population projections, the doubling time of the diabetic elderly population was estimated. Doubling time refers to the number of years it takes for the diabetic elderly population to double in size in Costa Rica under the assumption of a constant linear growth rate. Doubling time of the diabetic elderly population was also estimated for six hypothetical scenarios. Each scenario was under the assumptions of a linear population growth and a constant age-pattern of the incidence as observed in CRELES. For each scenario age-specific incidence rates were allowed to increase or decrease by 25, 50, and 75%, respectively.

Impact of diabetes on future healthcare costs

Future costs of health care for the elderly population were estimated using this study projected prevalence of diabetes and previously published estimations of current individual use of healthcare services [45]. Hospitalizations and outpatient consultations were modeled using two-part models, a common approach in health economics [18]. Costs were recorded based on the mean volume of utilization of hospitalizations and outpatient visits over a calendar year to avoid bias due to seasonality in the patterns of use of these services.

The costs of health care services used in this research are from the provider’s perspective, reported by the Costa Rican Social Security Fund (CCSS, for its Spanish acronym). Monthly current costs are publicly available at http://www.ccss.sa.cr. These monthly costs for each health care service are estimated by the CCSS as the total expenses incurred in one specific service divided by the total production in the same service over 1 month. Costs are reported in this study in United States Dollars from the year 2011 (2011 USD). We assumed that current patterns of healthcare services utilization remain constant in the future both in the diabetic as in the non-diabetic elderly.

Impact of diabetes on future life expectancy

The Lee-Carter method for mortality forecasting was used to forecast all-cause-mortality in this study. The Lee-Carter (LC) procedure is a stochastic model. It, therefore, allows for the quantification of uncertainty in the estimates. This method has been widely adopted in the USA, and it has also been used in the G7 countries and Australia [5]. Modifications and extensions have also been proposed to the method [6, 28].

Historical mortality rates for the 70s decade was not used in the time-series for mortality forecasting purposes. A significant decrease in infant mortality occurred during the 60s and 70s in Costa Rica. Using the 70s-decade mortality rates as an input for the estimation would have implied that such drastic mortality declines would have a chance to repeat in the future, which is not reasonable. Historical data on mortality from 1980 to 2010 was used to forecast 25 years of mortality up to the year 2035. Forecasts were estimated for (1) all-cause mortality and for (2) non-diabetes-related mortality. Forecasts were estimated using the LCFIT software [51], which produces a set of forecasted rates as an output. Median mortality rates by age-group and calendar year, as well as their corresponding confidence intervals, were estimated from the set of forecasted rates.

Using forecasted mortality rates to estimate life tables, two approaches were used to project the impact of diabetes in terms of life lost. They were based on estimations of life expectancy at birth (e0) and life expectancy at age 60 (e60).

In our first approach, we estimated e0 and one hypothetical scenario. We forecasted the total life expectancy at birth, and the total life expectancy at birth that would result from all mortality causes except diabetes.

In our second approach, we estimated e60, a commonly used indicator of longevity. We forecasted the total life expectancy at age 60, and two hypothetical scenarios. Our first hypothetical e60 scenario was the total e60 that would result from all mortality causes except diabetes. Our second hypothetical e60 scenario was the total e60 that would result from removing diabetes mortality and adding diabetes-caused mortality from a longitudinal competing-risks model. In this competing-risks model, the mortality hazard was computed as a function of diabetes-caused mortality, and the competing event was mortality due to any other cause. Forecasts were estimated with the assumption that the observed pattern and level of diabetes-caused mortality remains constant in the future.

Years of life lost to diabetes were estimated as the difference between the total life expectancy at age 60, minus the life expectancy at age 60 that would result from removing diabetes mortality and adding diabetes-caused mortality from the longitudinal competing risks model.

Results

As shown in Table 1, diabetes prevalence is 21% among the Costa Rican elderly population. The proportion of females is significantly higher among the diabetic as compared to the non-diabetic (61% vs. 50%, p < 0.01) population. More than half of the Costa Rican elderly are in the younger 60 to 69 age group. The oldest old, aged 80+ have a share of 10% among the diabetic elderly as compared to 16% among the non-diabetic (p < 0.01).

Table 1 Descriptive information of the CRELES Costa Rican elderly at baseline: 2004–2006 (weighted estimates)
Full size table

In general terms, risk factors and behaviors are different in the diabetic and the non-diabetic elderly population. The prevalence of central and general obesity as measured by waist circumference and body mass index is significantly higher among diabetic individuals (62% vs. 41, and 40% vs. 22%, p < 0.01). The prevalence of regular physical activity is significantly lower among the diabetic elderly (22% vs. 34%, p < 0.01). This physical activity measure includes both individuals who being able to exercise do not do so, and those whose health condition prevents beneficial physical activities. Among the diabetic elderly, hypertension is more prevalent (82% vs. 60%, p < 0.01). Myocardial infarction, ischemic heart attack and lung disease are also significantly higher among the diabetic (Table 1).

The mean costs of healthcare are significantly different between the diabetic and non-diabetic population. Hospitalization costs are significantly higher among diabetic elderly aged 60 to 79. Outpatient care costs are significantly higher for diabetic as compared to non-diabetic elderly population (Table 1).

Doubling time of the diabetic elderly population

Using the information on diabetes prevalence at CRELES first wave, as well as 5-year-age-group incidence and mortality rates, the size of the diabetic population was estimated back from the year 2006 (the end of CRELES wave 1) to the years 2001 and 1996. As a result, mean annualized growth rates for the 1996–2001 and 2001–2006 periods were estimated under the assumption of linear growth of the elderly diabetic population. Diabetes prevalence was projected to reach a 27% rate in 2025. Doubling time of the diabetic elderly population is estimated to occur in 13 calendar years in this country (Fig. 2).

Fig. 2
figure 2

Projections of diabetic population size, and prevalence rate in the elderly. Costa Rica: 1996–2025 (Left y-axis refers to population (thousands), represented as solid bars. Right y-axis refers to the prevalence of diabetes in the elderly population (%), represented as a dotted line)

Full size image

Considering population projections in this study are used to project healthcare costs into the future, a sensitivity analysis of the doubling time was conducted based on six different hypothetical scenarios, in which the incidence rates were allowed to increase or decrease by 25, 50, and 75%, respectively. The 13 years doubling time holds as a robust estimation (Table 2).

Table 2 Doubling time of the diabetic elderly population for hypothetical incidence level scenarios
Full size table

Projected economic costs of healthcare

The impact of diabetes prevalence on future healthcare costs was estimated based on the increase in total hospitalization and outpatient care costs. Hospitalization costs are higher than those of outpatient care. Costs associated with the hospitalization of diabetic elderly are projected to have a 38% share on total costs of hospitalizations in the elderly in the year 2025, which is 8 percentage points higher as compared to 20 years back in 2005 (Fig. 3). Outpatient consultations are projected to represent 34% of total consultation costs in the elderly in 2025, which is also 8 percentage points higher than in 2005 (Fig. 3).

Fig. 3
figure 3

Projected annualized mean costs of hospitalization and outpatient consultations of the Costa Rican elderly population under the assumption of linear growth of diabetes prevalence (2011 USD)

Full size image

Years of life lost to diabetes

The current total life expectancy at birth (e0) in Costa Rica is 80.07 years. Based on historical mortality, we forecast e0 to reach 81.35 years in 2035 (Fig. 4). If diabetes were not a direct cause of death for any individual, e0 would be higher. Under the hypothetical scenario of deleting diabetes as a direct cause of death for any individual aged 30+, we forecast e0 would reach 82.02 years in 2035 (Fig. 5).

Fig. 4
figure 4

Forecast of total life expectancy at birth based on all-cause mortality. Costa Rica: 1980–2035

Full size image
Fig. 5
figure 5

Forecast of hypothetical total life expectancy removing diabetes as a cause of death. Costa Rica: 1980–2035

Full size image

When studying the impact of a specific disease on mortality, it is often assumed that one can subtract off the number of deaths caused by that specific disease. However, when studying cause-specific mortality, it is wiser to assume a counterfactual scenario, in which competing risks of death are computed [36]. Both approaches to the estimation of life expectancy at age 60 are shown in Table 3, as scenarios (2) and (3), respectively. Diabetes is removed as a cause of death in scenario (2). Whereas e60 estimation results from removing diabetes mortality and adding diabetes-caused mortality from a longitudinal competing risk model in scenario (3). Years of life lost to diabetes were estimated based on the latter scenario, which yields a finer estimation of the impact.

Table 3 Forecast of total life expectancy at age 60 (95% CI). Costa Rica: 2025 and 2035
Full size table

We estimate a seven-months of life loss in 2025 as an impact of diabetes on e60. The same life loss estimation holds for 2035. These estimations and their corresponding confidence intervals are presented in Table 3.

Discussion

Gender differences are found among the diabetic elderlies. Although the non-diabetic population is equally distributed among males and females, the diabetic population is heavily represented by females in elderly Costa Ricans. These gender differences have not been consistently found in the literature. Nonetheless, it has been hypothesized that these differences may come from a lower prevalence of obesity and from a late detection of the condition for males in this country [45].

Diabetes risk factors and behaviors are not homogenously distributed among the population. Because of their modifiable nature, they constitute a window of opportunity to modulate intermediate and final health outcomes. Obesity, which is the primary risk factor for this condition, is significantly more prevalent among the diabetic elderly. Had this risk factor been modified in previous stages of individuals’ life cycle, differences between diabetic and non-diabetic population would probably be smaller. Along the same lines, regular physical activity is less prevalent in this population, which may reflect a lifetime behavior.

Age differences found between diabetic and non-diabetic elderly in this study are a result of the diabetes associated premature mortality. Diabetes-caused mortality has a greater share of general mortality at younger ages. As it has also been shown in other studies, this condition is associated with increased risks of death from all causes [23], which translates into premature mortality.

Improving population health is the main goal for any health system. Our results show that diabetes leads to a loss of about 7 months on life expectancy at age 60. Life loss evidenced in this study is known to be preceded by a loss of quality of life. Previously published studies on health-related quality of life (HRQoL) in Finland, for example, have found that as compared to the non-diabetic population, HRQoL scores of the diabetic population are negatively affected especially as the duration of disease increases [46]. Studies on disability-adjusted life expectancy in Cuba, for example, found that diabetes decreased life expectancy approximately less than 1 year [19]. Another study of Cárdenas, [11] reported that diabetes impact on quality-of-life occurred mainly in elder low socioeconomic status women, with few support networks, and without healthcare insurance.

Taking into account the burden of DM2 both in terms of the impact on the individual and the costs it represents for the healthcare system, it is important to analyze alternatives to improve lifestyles. According to García, Camarelles, Muñoz, Gómez, Arangoe, Ramírez, and colleagues [16], some lifestyle changes like physical activity and healthy eating have shown to improve population health and decrease the burden of the disease by reducing its incidence and the complications associated to those who are already ill. These initiatives are important to be applied in all healthcare levels, but especially in the first level of care.

A deterministic forecast specifies time-changes over the forecast period in terms of deterministic (i.e., not random) assumptions. In the stochastic forecast, different from deterministic projections, the role of the forecaster’s subjective judgment is reduced [27] and the uncertainty in the estimates may be quantified. Based on a stochastic projection methodology, our study yielded a robust estimation of the diabetes prevalence projection and the doubling time of the diabetic elderly in Costa Rica. Using the same CRELES dataset, but a deterministic projection methodology, which was a variation of the cohort-component method, [7] attained remarkably similar results. According to our study, 27% of the elderly population is projected to be diabetic by 2025 in Costa Rica. Brenes [7] estimated a 28% prevalence of diabetes in the elderly for the same year. Our study estimates that the size of the diabetic elderly population will double in 13 years. Along the same line, [7] estimated it would take 25 years for Costa Rican diabetic elderly population size to quadruple. The main feature of a stochastic approach to forecast is that estimations can be accompanied by confidence intervals [25], as shown in this study.

Hypothetical scenarios of decreasing diabetes incidence rates would imply a great effort from a public health point of view. Still, as this study shows, the resulting doubling time would not dramatically change under different scenarios. Even for the most optimistic scenario of 75% decrease in the incidence rate, doubling time would be 13,5 calendar years, which is very close to the 13,0 years estimated for the counterfactual. Doubling time of diabetic elderly population is mainly driven by the population aging inertia.

Obesity, a risk factor for other chronic conditions, is associated with a significant burden of hypertension and myocardial infarction which not only translates into a lower life expectancy as shown in our results but also into a lower quality of life. A previous study has reported that 20 years after diagnosis of diabetes there is a 45% chance of heart failure and a 65% chance of retinopathy [24]. Diabetes is associated with long-term damage, dysfunction, and failure of organs, especially the eyes, kidneys, nerves, heart, and blood vessels. Diabetes also significantly increases the risk of stroke, chronic kidney disease, cancer and all-cause mortality [49]. For a Costa Rican urban population of adult diabetic patients, [26] have reported a 33.6% prevalence of nephropathy, 30.6% prevalence of neuropathy, and 24.8% prevalence of microproteinuria. This high prevalence of complications causes a diabetic population to make heavier use of outpatient consultations and hospitalizations, which adds to the burden to the healthcare system.

The prevalence of DM2 is a challenge for all countries in the region, because of its costs to the healthcare system and the high mortality it causes. In Costa Rica elderly diabetic patients are more inclined to be hospitalized and to make use of outpatient consultations [45]. As the diabetic elderly population increases, the total costs of hospitalizations and outpatient care will also increase, as shown in this study. A higher share of costs associated with diabetic elderly is projected to occur in the near future.

Gender and geographical inequalities in diabetes incidence, prevalence and mortality have been previously described in this elderly Costa Rican population [45]. Furthermore, this study describes existing inequalities such as higher obesity, lower regular physical activity, and higher incidence of myocardial infarction, ischemic heart attack and lung disease among diabetic individuals. Because Costa Rica has a universal and solidary healthcare system, higher expenditures associated with diabetes inequalities increase the burden on the healthcare system. This increased burden caused by diabetes in the elderly may also have an impact on the attention of other health conditions for the general population.

This increasing burden of diabetes has already been perceived by Costa Rican authorities. A research conducted in a Costa Rican population had shown that diabetic individuals made 1.55 more medical visits and had 1.98 times more hospitalizations than their non-diabetic peers [33]. The most frequent causes of consultation in the elderly (22%) are those related to the circulatory system, which include hypertension. The second most important causes (16%) are endocrine, nutritional and metabolism pathologies, which include diabetes [13]. These causes of morbidity, diabetes being one of the most relevant, represent high costs to the healthcare system.

Diabetes prevalence will continue to rise in the elderly. This increased prevalence is the main reason for the growing burden of diabetes not only in developing but also in developed countries [48]. Previous studies have shown that in individuals at high risk, a combination of weight loss, physical activity and dietary advice leads to a significant reduction in incidence. Prevention using lifestyle interventions as a strategy lead to higher cost-effective reductions in incidence among populations at high risk than strategies that use drugs for prevention [55].

Because it is also expected that a substantial proportion of diabetes will arise in individuals not identified as being at high risk, broader strategies are also necessary. These strategies include public policy to modify the obesogenic environment in which populations live [54]. It becomes necessary to generate public policies with actions focused on promoting health that allow the population to have equitable access to health information, spaces for physical activity and healthy eating. Policies should be adapted to different age groups and populations, understanding that early-stage actions influence life cycle behaviors. Local support is important for policy implementation because the local level is responsible for operationalization of actions, and the local actors are the ones who know better which populations are disadvantaged.

Because of the use of self-reported measures, information bias is a limitation of this study, which might result in an under estimation of the prevalence of diabetes. Selection bias is also a limitation. Reported results are susceptible to selection bias because they rely on the population that survived at least to the age of 60 in 2005, when the baseline survey was conducted. Another limitation of this study is the impossibility of ascertaining birth cohort effects. Observed diabetes patterns may result from cohort effects that have occurred over time. It may be hypothesized for example, that individuals from older cohorts might have been less exposed to risk factors such as physical inactivity or high fat diets than individuals from younger cohorts who are now experiencing higher rates of diabetes prevalence. In this study, the same participants recruited for baseline, were re-interviewed for the second and third waves. Different from some panel studies, cohorts of individuals were not therefore renewed within each wave in this study. As a result, a large enough sample size of individuals within cohorts is not feasible, and birth cohort effects were not possible to assess in this study.

Conclusion

The diabetic population is on the rise. Costs of healthcare for the diabetic elderly are projected to have a growing share of total healthcare costs to the system in Costa Rica. Risk factors and behavioral differences between the diabetic and the non-diabetic population should be further studied. Obesity reduction and physical activity promotion must be taken into account in the formulation of public policies for diabetes prevention in this country. The challenge for public prevention policies is to develop and evaluate ways of addressing the underlying factors that make individuals vulnerable to the condition. Diabetes prevention, or at least delaying its onset, are possible. This would reduce the impact of the diabetic epidemic in the Costa Rican elderly population.

Health is not exclusively determined by individual choice; it is rather a process mediated by social determinants. Biological characteristics, but also lifestyle, human environment, health systems and policies all have an impact on human health. Type 2 diabetes, more than just a disease, is a result of social and cultural dynamics that can be modulated by appropriate policies.

Although problematic, having common risk factors for a number of metabolic conditions, including diabetes, is also a window of opportunity. Lifestyles are modifiable and although this is clearly not an easy task, public policies should redirect efforts towards population behavioral modifications. Controlling population nutritional status with strategies intervening not only with individuals but also with their environments would bring the benefits of preventing more than one condition while also simultaneously reducing costs.

The most highly effective interventions to reduce morbidity, premature mortality, and the incidence of complications that derive from diabetes are education for lifestyle change and the creation of environments in which individual behavioral initiatives can succeed. As stated by Yach et al. [58] overweight and obesity have become to diabetes what tobacco is to lung cancer. Acting on diabetes preventable risk factors is therefore mandatory to slow down diabetes incidence. Efforts to impact the quantity and quality of life of incoming cohorts should focus on primary healthcare services including extramural activities that go beyond medical consultations. Health promotion and prevention must be encouraged as strategies to act on diabetes risk factors in order to improve elderly population health.

Availability of data and materials

The datasets used during the current study are publicly available from http://creles.berkeley.edu:1313/CRdata.pl. Other materials may be available from the corresponding author on reasonable request.

References

  1. Albala C, Vio F, Kain J, Uauy R. Nutrition transition in Latin America: the case of Chile. Nutr Rev. 2001;59(6):170–6.

    Article  CAS  PubMed  Google Scholar 

  2. Andrade FCD. Functional disability and health inequality among elderly Latinos: The diabetes mellitus burden. (Doctoral dissertation, University of Wisconsin-Madison). Available from ProQuest Dissertations and Thesis database. (UMI No. 3245628). 2006.

  3. Barceló A. Diabetes and hypertension in the Americas. West Indian Med J. 2000;49(4):262–5.

    PubMed  Google Scholar 

  4. Barcelo A, Gregg E, Pastor-Valero M, Robles S. Waist circumference, BMI and the prevalence of self-reported diabetes among the elderly of the United States and six cities of Latin America and the Caribbean. Diabetes Res Clin Pract. 2007;78(3):418–27.

    Article  CAS  PubMed  Google Scholar 

  5. Booth H, Tickle L. The future aged: new projections of Australia’s elderly population. Australasian J Ageing. 2003;22(4):196–202.

    Article  Google Scholar 

  6. Booth H, Maindonald J, Smith L. Applying Lee-Carter under conditions of variable mortality decline. Popul Stud. 2002;56:325–36.

    Article  Google Scholar 

  7. Brenes G. The effect of early life events on the burden of diabetes mellitus among Costa Rican elderly: estimates and projections. (doctoral dissertation, University of Wisconsin-Madison). Available from ProQuest dissertations and thesis database. (UMI no. 3314166); 2008a.

    Google Scholar 

  8. Brenes-Camacho G, Rosero-Bixby L. Metabolic control in a nationally representative diabetic elderly sample in Costa Rica: patients at community health centers vs. patients at other health care settings. BMC Int Health Hum Rights. 2008;8:5. https://doi.org/10.1186/1472-698X-8-5.

  9. Brown JE. Nutrición en las diferentes etapas de la vida. 3ª Edición ed. México: McGraw Hill; 2008.

    Google Scholar 

  10. Caldwell J. Routes to low mortality in poor countries. Popul Dev Rev. 1986;12(2):171–220.

    Article  Google Scholar 

  11. Cárdenas VM, Pedranza C, Lerma R. Calidad de vida del paciente con diabetes Mellitus tipo 2. Ciencia UANL. 8(003). Monterrey; 2005. p. 351–7. Recovered by https://www.redalyc.org/pdf/402/40280308.pdf.

  12. Centro Centromelinaamericano de Población. (2019). Proyecciones Nacionales de Poblaciones de Costa Rica 1950–2100. Recovered by: https://censos.ccp.ucr.ac.cr/index.php/censos_c?censo=crproyna.

    Google Scholar 

  13. Chaves, O. & León, M. (2010). Acceso y uso de los servicios de salud de la Caja Costarricense de Seguro Social por parte de la población adulta mayor. Dirección de Compra de Servicios de Salud, Gerencia División Administrativa, Caja Costarricense de Seguro Social. Documento preparado para el II Informe estado de situación de la persona adulta mayor en Costa Rica, UCR/CONAPAM.

    Google Scholar 

  14. Coale A, Demeny P, Vaughan B. Regional model life tables at very low levels of mortality. Popul Index. 1983;55(4):613–43.

    Article  Google Scholar 

  15. Colchero MA, Popkin BM, Rivera JA, Ng SW. Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study. BMJ. 2018;352:h6704. https://doi.org/10.1136/bmj.h6704.

    Article  Google Scholar 

  16. Córdoba García R, Camarelles Guillem F, Muñoz Seco E, Gómez Puente JM, José Arango JS, Ramírez Manent JI, Martín Cantera C, Campo Giménez MD, Revenga Frauca J, Grupo de Educación Sanitaria y Promoción de la Salud del PAPPS. Recomendaciones sobre el estilo de vida. Actualización PAPPS 2018. Atención primaria. 2018;50(Suppl 1):29–40. https://doi.org/10.1016/S0212-6567(18)30361-5.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cubero-Alpizar C, Rojas-Valenciano L. Comportamiento de la diabetes mellitus en Costa Rica. Revista Horizonte Sanitario; 2017. https://doi.org/10.19136/hs.a16n3.1871.

    Book  Google Scholar 

  18. Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing health care utilization and costs. Annu Rev Public Health. 1999;20:125–44. https://doi.org/10.1146/annurev.publhealth.20.1.125.

    Article  CAS  PubMed  Google Scholar 

  19. Domínguez, E., Seuc, A., Díaz, O., Aldana, D. (2010). Esperanza de vida saludable asociada a la diabetes en cuba: años 1990 y 2003. Revista Cubana de Endocrinología. 21(1). Recovered by: http://scielo.sld.cu.

  20. Grisales-Romero H, Marín D, Gónzales-Gómez D, Grajales IC, Porras SM, Colorado-Betancur LJ, Lopera-Velasquez ML. Pérdida de años de vida saludable por la población de Medellín, Colombia 2006–2012. Papeles de población. 2016. https://doi.org/10.22185/24487147.2018.95.04.

  21. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–46.

    Article  CAS  PubMed  Google Scholar 

  22. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle and the risk of type 2 diabetes in women. N Engl J Med. 2001;345:790–7.

    Article  CAS  PubMed  Google Scholar 

  23. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. 20 years of follow-up. Arch Intern Med. 2007;161:1717–23.

    Article  Google Scholar 

  24. Ibarra, E. and Cantú P. (2003). Años de vida productive perdidos por complicaciones crónicas de diabetes mellitus en población económicamente activa. Instituto Mexicano del Seguro Social. Recovered by http://respyn.uanl.mx/index.php/respyn/article/download/105/89.

    Google Scholar 

  25. Keyfitz N, Caswell H. Applied Mathematical Demography. Third Edition. Springer; 2005.

    Google Scholar 

  26. Laclé-Murray A, Valero LF. Prevalencia de nefropatía diabética y sus factores de riesgo en un área urbano marginal de la meseta Central de Costa Rica. Acta Médica Costarricense. 2009;51(1):26–33 ISSN 0001-6002.

    Google Scholar 

  27. Lee R, D., & Miller, T. Evaluating the performance of the Lee-Carter method for forecasting mortality. Demography. 2001;38(4):537–49.

    Article  CAS  PubMed  Google Scholar 

  28. Li N, Lee R. Coherent mortality forecasts for a group of populations: an extension of the Lee-Carter method. Demography. 2005;43(3):575–94.

    Article  Google Scholar 

  29. McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol. 2009;64A(2):256–63.

    Article  Google Scholar 

  30. Méndez-Chacón E, Santamaría –Ulloa, C., & Rosero-Bixby L. Factors associated with hypertension prevalence, unawareness and treatment among Costa Rican elderly. BMC Public Health. 2008;8:275. https://doi.org/10.1186/1471-2458-8-275.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ministerio de educación pública. (2011). Decreto 36910. Reglamento para el funcionamiento y administración del servicio de soda en los centros educativos públicos.

    Google Scholar 

  32. Ministerio de Salud, Instituto Costarricense de Investigaciones en Nutrición y Salud, Caja Costarricense del Seguro Social, Instituto Nacional de Estadística y Censos, & Instituto Costarricense sobre Drogas. (2009). Encuesta Nacional de Nutrición Costa Rica, 2008–2009. Antropometría. Retrieved from: http://www.ministeriodesalud.go.cr.

    Google Scholar 

  33. Morice A, Roselló M, Aráuz AG, Sánchez G, Padilla G. Diabetes mellitus en Costa Rica: un análisis interdisciplinario, Instituto de Investigación y Enseñanza en Nutrición y Salud. (Inciensa). Tres Ríos: Serie de documentos técnicos; 1999.

    Google Scholar 

  34. Population Reference Bureau. 2011 world population data sheet. Washington, DC: Population Reference Bureau; 2019.

    Google Scholar 

  35. Prentice A. Fires of life: the struggles of an ancient metabolism in a modern world. Nutr Bull. 2001;26:13–27.

    Article  Google Scholar 

  36. Preston SH, Heuveline P, Guillot M. Demography: measuring and modeling population processes. Oxford: Blackwell Publishers Ltd.; 2002.

    Google Scholar 

  37. Redondo M, Hernandez-Aguado I, Lumbreras B. The impact of the tax on sweetened beverages: a systematic review. Am J Clin Nutr. 2018;108(3):548–63. https://doi.org/10.1093/ajcn/nqy135.

    Article  PubMed  Google Scholar 

  38. Rehkopf D, Dow H, Rosero-Bixby L. Differences in the association of cardiovascular risk factors with education: a comparison of Costa Rica (CRELES) and the USA (NHANES). J Epidemiol Community Health. 2010;64(9):821–8. https://doi.org/10.1136/jech.2009.086926.

    Article  PubMed  Google Scholar 

  39. Roselló M, Aráuz AG, Padilla G. Prevalencia de diabetes mellitus autorreportada en Costa Rica, 1998. Acta Médica Costarricense. 2004;46(4):190–5 ISSN: 0001–6002.

    Google Scholar 

  40. Rosero-Bixby L. Socioeconomic development, health interventions, and mortality decline in Costa Rica. Scand J Soc Med Suppl. 1991;46:33–42.

    CAS  PubMed  Google Scholar 

  41. Rosero-Bixby L. Adult mortality decline in Costa Rica. In: Timaeus IM, Chackiel J, Rusicka L, editors. Adult Mortality in Latin America. Chapter 9. Oxford: Clarendon Press; 1996.

    Google Scholar 

  42. Rosero-Bixby L. Tendencias en la mortalidad y esperanza de vida. Costa Rica 1970-2001. San José: Proyecto Estado de la Nación; 2002.

    Google Scholar 

  43. Rosero-Bixby L, Dow WH. Surprising SES gradients in mortality, health, and biomarkers in a Latin American population of adults. J Gerontol B Psychol Sci Soc Sci. 2009;64B(1):105–17. https://doi.org/10.1093/geronb/gbn004.

    Article  PubMed Central  Google Scholar 

  44. Rosero-Bixby L, Dow WH, Fernández X. CRELES: Costa Rican longevity and healthy aging study. Methods, wave 3. Berkeley: Department of Demography, University of California, Berkeley. Electronic document; 2013. http://www.creles.berkeley.edu, Accessed 18 June 2020.

    Google Scholar 

  45. Santamaria-Ulloa C, Montero-López M, Rosero-Bixby L. Diabetes epidemics: inequalities increase the burden on the healthcare system. Health Policy Plan. 2019;34:ii45–55. https://doi.org/10.1093/heapol/czz109.

    Article  PubMed  Google Scholar 

  46. Schanner C, Falck A, Keskitalo A, Hautala N. Health-related quality of life of Finnish patients with diabetes. Scand J Public Health. 2016;44:765–71. https://doi.org/10.1177/1403494816666732.

    Article  PubMed  Google Scholar 

  47. Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1–2):165–73. https://doi.org/10.1300/J018v05n01_09.

    Article  Google Scholar 

  48. Sloan FA, Bethel MA, Ruiz D, Shea AH, Feinglos MN. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med. 2008;168(2):192–9.

    Article  PubMed  Google Scholar 

  49. So WY, Yang X, Ma RCW, Kong APS, Lam CWK, Ho CS, et al. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-the Hong Kong diabetes registry. Diabetes Metab Res Rev. 2008;24:238–46.

    Article  PubMed  Google Scholar 

  50. Solli O, Jensen T, Kristiansen IS. Diabetes: cost of illness in Norway. BMC Endocr Disord. 2010;10:15. https://doi.org/10.1186/1472-6823-10-15.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Sprague, W. (2009). LCFIT. Web based software for estimating the Lee-Carter method for modeling and forecasting mortality, with extensions to coherent forecasts of Li and Lee, and Lee-Carter method with sparse and incomplete data. Retrieved from: http://lcfit.demog.berkeley.edu/. Last visited on November 30, 2012.

    Google Scholar 

  52. StataCorp. Stata Statistical Software: Release 12.0. College Station: Stata Corporation; 2013.

    Google Scholar 

  53. Unger JP, De Paepe P, Buitrón R, Soors W. Costa Rica: achievements of heterodox health policy. Am J Public Health. 2008;98(4):636–46.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Unwing N, Whiting D, Roglic G. Social determinants of diabetes and challenges of prevention. Lancet. 2010;375:2204–5.

    Article  Google Scholar 

  55. Venkat-Narayan KM, Zhang P, Kanaya AM, Williams DE, Engelgau MM, Imperatore G, et al. Diabetes: the pandemic and potential solutions. In: Jamison DT, et al., editors. Disease control priorities in developing countries. Washington, DC/New York: World Bank, Oxford University Press; 2006. p. 591–604.

    Google Scholar 

  56. World Health Organization. Obesity: preventing and managing the global epidemic: Report of a WHO consultation. Geneva, Switzerland. 2000. Technical Report Series no. 894.

  57. World Health Organization. (2018). Diabetes: key facts. Recovered by: https://www.who.int/news-room/fact-sheets/detail/diabetes.

    Google Scholar 

  58. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006;12(1):62–6.

    Article  CAS  PubMed  Google Scholar 

  59. Zimmet P, Alberti KG, Shaaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The CRELES project is a longitudinal study of the Universidad de Costa Rica, carried on by the Centro Centroamericano de Población in collaboration with the Instituto de Investigaciones en Salud, with the support of the Wellcome Trust foundation (Grant No. 072406). Principal Investigator: Luis Rosero-Bixby. Co-principal investigators: Xinia Fernández and William H. Dow. Collaborating investigators: Ericka Méndez, Guido Pinto, Hannia Campos, Kenia Barrantes, Floribeth Fallas, Gilbert Brenes and Fernando Morales. Informatics and support staff: Daniel Antich, Aaron Ramírez, Jeisson, Hidalgo, Juanita Araya, and Yamileth Hernández. Field workers: José Solano, Julio Palma, Jenny Méndez, Maritza Araúz, Mabelyn Gómez, Marcela Rodríguez, Geovanni Salas, Jorge Vindas and Roberto Patiño. The authors express their gratitude to Hazel Quesada-Leitón for her support in data management. They also thank the manuscript reviewers for their thoughtful comments.

Funding

The following sources of funding were awarded to the corresponding author: Traineeship from the National Institutes of Health’s (NIH) Fogarty International Center (FIC) training programme (5D43TW001586) at the Center for Demography and Ecology, Universtiy of Wisconsin-Madison. Scholarships from the Costa Rican Ministry of Health and the Universidad de Costa Rica.

Author information

Authors and Affiliations

  1. Instituto de Investigaciones en Salud, Universidad de Costa Rica, San José, Costa Rica

    Carolina Santamaría-Ulloa & Melina Montero-López

Authors
  1. Carolina Santamaría-Ulloa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melina Montero-López
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Methodology, planning and design: CS-U. Data collection: CS-U. Data analysis and interpretation: CS-U and MM-L. Manuscript preparation for publication: CS-U and MM-L. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Carolina Santamaría-Ulloa.

Ethics declarations

Ethics approval and consent to participate

The CRELES Study was approved by the Ethical Science Committee of the University of Costa Rica (reference: VI-763-CEC-23-04). All the databases of the study have been made anonymous (the name or identifier has been removed) to avoid risks to the privacy of the participants.

Consent for publication

Not applicable.

Competing interests

None declared.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santamaría-Ulloa, C., Montero-López, M. Projected impact of diabetes on the Costa Rican healthcare system. Int J Equity Health 19, 172 (2020). https://doi.org/10.1186/s12939-020-01291-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12939-020-01291-4

International Journal for Equity in Health

ISSN: 1475-9276

Contact us